{"entity":{"type":"insider","cik":"0001419701","url":"/insider/0001419701","json_url":"/insider/0001419701.json","name":"Longitude Venture Partners L.P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":55,"n_filings":16,"first":"2009-02-10","last":"2017-12-12","span_basis":"filed_date"},"name_variants":[{"name":"Longitude Venture Partners L.P.","source":"filing","n_filings":15,"first_seen":"2009-10-19","last_seen":"2017-12-12"},{"name":"Longitude Venture Partners LP","source":"filing","n_filings":1,"first_seen":"2009-02-10","last_seen":"2009-02-10"}],"transactions":[{"id":4231435,"accession":"0001209191-17-065191","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-065191","line_url":"/filing/0001209191-17-065191","is_derivative":false,"issuer_cik":"0001253886","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001253886","owner_cik":null,"owner_name":"Longitude Capital Associates, L.P.; Longitude Venture Partners L.P.; ENRIGHT PATRICK G; Longitude Capital Partners, LLC; Tammenoms Bakker Juliet","owner_display_name":"Longitude Capital Associates, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000000.0,"shares_display":"1,000,000","price_per_share":17.34,"price_display":"17.34","price_state":"stated","total_value":17340000.0,"total_display":"17,340,000.00","total_whole":"17,340,000","shares_owned_after":2276222.0,"shares_owned_after_display":"2,276,222","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-12-08","filed_date":"2017-12-12","scope":"insider","n_lines":2},{"id":2968763,"accession":"0001209191-16-152057","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-16-152057","line_url":"/filing/0001209191-16-152057","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":null,"owner_name":"Tammenoms Bakker Juliet; Longitude Venture Partners L.P.; Longitude Capital Partners, LLC; Longitude Capital Associates, L.P.","owner_display_name":"Tammenoms Bakker Juliet","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14741.0,"shares_display":"14,741","price_per_share":9.3869,"price_display":"9.39","price_state":"stated","total_value":138372.2929,"total_display":"138,372.29","total_whole":"138,372","shares_owned_after":13775899.0,"shares_owned_after_display":"13,775,899","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-25","filed_date":"2016-11-25","scope":"insider","n_lines":2},{"id":2968757,"accession":"0001209191-16-152057","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-16-152057","line_url":"/filing/0001209191-16-152057","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":null,"owner_name":"Tammenoms Bakker Juliet; Longitude Venture Partners L.P.; Longitude Capital Partners, LLC; Longitude Capital Associates, L.P.","owner_display_name":"Tammenoms Bakker Juliet","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12600.0,"shares_display":"12,600","price_per_share":9.3038,"price_display":"9.30","price_state":"stated","total_value":117227.88,"total_display":"117,227.88","total_whole":"117,228","shares_owned_after":13790350.0,"shares_owned_after_display":"13,790,350","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-23","filed_date":"2016-11-25","scope":"insider","n_lines":2},{"id":2968746,"accession":"0001209191-16-152057","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-152057","line_url":"/filing/0001209191-16-152057","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":null,"owner_name":"Tammenoms Bakker Juliet; Longitude Venture Partners L.P.; Longitude Capital Partners, LLC; Longitude Capital Associates, L.P.","owner_display_name":"Tammenoms Bakker Juliet","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9600.0,"shares_display":"9,600","price_per_share":9.3297,"price_display":"9.33","price_state":"stated","total_value":89565.12,"total_display":"89,565.12","total_whole":"89,565","shares_owned_after":13802702.0,"shares_owned_after_display":"13,802,702","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-22","filed_date":"2016-11-25","scope":"insider","n_lines":2},{"id":3259588,"accession":"0001209191-16-151526","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-16-151526","line_url":"/filing/0001209191-16-151526","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":null,"owner_name":"Tammenoms Bakker Juliet; Longitude Capital Associates, L.P.; Longitude Capital Partners, LLC; Longitude Venture Partners L.P.","owner_display_name":"Tammenoms Bakker Juliet","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":118385.0,"shares_display":"118,385","price_per_share":9.386,"price_display":"9.39","price_state":"stated","total_value":1111161.61,"total_display":"1,111,161.61","total_whole":"1,111,162","shares_owned_after":13812113.0,"shares_owned_after_display":"13,812,113","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-21","filed_date":"2016-11-21","scope":"insider","n_lines":2},{"id":3259567,"accession":"0001209191-16-151526","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-16-151526","line_url":"/filing/0001209191-16-151526","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":null,"owner_name":"Tammenoms Bakker Juliet; Longitude Capital Associates, L.P.; Longitude Capital Partners, LLC; Longitude Venture Partners L.P.","owner_display_name":"Tammenoms Bakker Juliet","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100562.0,"shares_display":"100,562","price_per_share":9.4736,"price_display":"9.47","price_state":"stated","total_value":952684.1632,"total_display":"952,684.16","total_whole":"952,684","shares_owned_after":13928171.0,"shares_owned_after_display":"13,928,171","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-18","filed_date":"2016-11-21","scope":"insider","n_lines":2},{"id":3259556,"accession":"0001209191-16-151526","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-151526","line_url":"/filing/0001209191-16-151526","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":null,"owner_name":"Tammenoms Bakker Juliet; Longitude Capital Associates, L.P.; Longitude Capital Partners, LLC; Longitude Venture Partners L.P.","owner_display_name":"Tammenoms Bakker Juliet","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":325153.0,"shares_display":"325,153","price_per_share":9.6434,"price_display":"9.64","price_state":"stated","total_value":3135580.4402,"total_display":"3,135,580.44","total_whole":"3,135,580","shares_owned_after":14026757.0,"shares_owned_after_display":"14,026,757","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-17","filed_date":"2016-11-21","scope":"insider","n_lines":2},{"id":2602253,"accession":"0001209191-16-151019","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-16-151019","line_url":"/filing/0001209191-16-151019","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":null,"owner_name":"Longitude Capital Associates, L.P.; Longitude Capital Partners, LLC; Tammenoms Bakker Juliet; Longitude Venture Partners L.P.","owner_display_name":"Longitude Capital Associates, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17394.0,"shares_display":"17,394","price_per_share":9.5087,"price_display":"9.51","price_state":"stated","total_value":165394.3278,"total_display":"165,394.33","total_whole":"165,394","shares_owned_after":14345521.0,"shares_owned_after_display":"14,345,521","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-16","filed_date":"2016-11-17","scope":"insider","n_lines":2},{"id":2602243,"accession":"0001209191-16-151019","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-151019","line_url":"/filing/0001209191-16-151019","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":null,"owner_name":"Longitude Capital Associates, L.P.; Longitude Capital Partners, LLC; Tammenoms Bakker Juliet; Longitude Venture Partners L.P.","owner_display_name":"Longitude Capital Associates, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":157453.0,"shares_display":"157,453","price_per_share":9.5534,"price_display":"9.55","price_state":"stated","total_value":1504211.4902,"total_display":"1,504,211.49","total_whole":"1,504,211","shares_owned_after":14362573.0,"shares_owned_after_display":"14,362,573","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-15","filed_date":"2016-11-17","scope":"insider","n_lines":2},{"id":8373282,"accession":"0001209191-15-042801","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-15-042801","line_url":"/filing/0001209191-15-042801","is_derivative":false,"issuer_cik":"0001253886","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001253886","owner_cik":null,"owner_name":"Longitude Venture Partners L.P.; Longitude Capital Partners, LLC; Tammenoms Bakker Juliet; ENRIGHT PATRICK G; Longitude Capital Associates, L.P.","owner_display_name":"Longitude Venture Partners L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200000.0,"shares_display":"200,000","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":2400000.0,"total_display":"2,400,000.00","total_whole":"2,400,000","shares_owned_after":3256572.0,"shares_owned_after_display":"3,256,572","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-05-12","filed_date":"2015-05-14","scope":"insider","n_lines":2},{"id":8449682,"accession":"0001144204-15-018083","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001144204-15-018083","line_url":"/filing/0001144204-15-018083#line-7","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":null,"owner_name":"Longitude Capital Partners, LLC; Longitude Capital Associates, L.P.; Tammenoms Bakker Juliet; Longitude Venture Partners L.P.","owner_display_name":"Longitude Capital Partners, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":554348.0,"shares_display":"554,348","price_per_share":5.65,"price_display":"5.65","price_state":"stated","total_value":3132066.2,"total_display":"3,132,066.20","total_whole":"3,132,066","shares_owned_after":13677121.0,"shares_owned_after_display":"13,677,121","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-24","filed_date":"2015-03-24","scope":"insider"},{"id":8449664,"accession":"0001144204-15-018083","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001144204-15-018083","line_url":"/filing/0001144204-15-018083","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":null,"owner_name":"Longitude Capital Partners, LLC; Longitude Capital Associates, L.P.; Tammenoms Bakker Juliet; Longitude Venture Partners L.P.","owner_display_name":"Longitude Capital Partners, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":535397.0,"shares_display":"535,397","price_per_share":5.85,"price_display":"5.85","price_state":"stated","total_value":3132072.45,"total_display":"3,132,072.45","total_whole":"3,132,072","shares_owned_after":12844650.0,"shares_owned_after_display":"12,844,650","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-20","filed_date":"2015-03-24","scope":"insider","n_lines":3},{"id":6200515,"accession":"0001144204-14-069746","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001144204-14-069746","line_url":"/filing/0001144204-14-069746","is_derivative":false,"issuer_cik":"0001419701","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001419701","owner_cik":null,"owner_name":"Tammenoms Bakker Juliet; Longitude Capital Partners, LLC; Longitude Capital Associates, L.P.; Longitude Venture Partners L.P.","owner_display_name":"Tammenoms Bakker Juliet","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5104.0,"shares_display":"5,104","price_per_share":31.61160556426332,"price_display":"31.61","price_state":"stated","total_value":161345.6348,"total_display":"161,345.63","total_whole":"161,346","shares_owned_after":1406622.0,"shares_owned_after_display":"1,406,622","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-11-18","filed_date":"2014-11-19","scope":"insider","n_lines":4},{"id":6200497,"accession":"0001144204-14-069746","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001144204-14-069746","line_url":"/filing/0001144204-14-069746","is_derivative":false,"issuer_cik":"0001419701","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001419701","owner_cik":null,"owner_name":"Tammenoms Bakker Juliet; Longitude Capital Partners, LLC; Longitude Capital Associates, L.P.; Longitude Venture Partners L.P.","owner_display_name":"Tammenoms Bakker Juliet","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":482026.0,"shares_display":"482,026","price_per_share":32.78831955288719,"price_display":"32.79","price_state":"stated","total_value":15804822.5208,"total_display":"15,804,822.52","total_whole":"15,804,823","shares_owned_after":1683178.0,"shares_owned_after_display":"1,683,178","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-11-17","filed_date":"2014-11-19","scope":"insider","n_lines":6},{"id":6546654,"accession":"0001144204-14-060795","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-14-060795","line_url":"/filing/0001144204-14-060795","is_derivative":false,"issuer_cik":"0001419701","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001419701","owner_cik":null,"owner_name":"Longitude Capital Associates, L.P.; Longitude Capital Partners, LLC; Tammenoms Bakker Juliet; Longitude Venture Partners L.P.","owner_display_name":"Longitude Capital Associates, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":943.0,"shares_display":"943","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":28290.0,"total_display":"28,290.00","total_whole":"28,290","shares_owned_after":1883769.0,"shares_owned_after_display":"1,883,769","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-10-09","filed_date":"2014-10-14","scope":"insider","n_lines":2},{"id":6262754,"accession":"0001144204-14-060376","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-14-060376","line_url":"/filing/0001144204-14-060376","is_derivative":false,"issuer_cik":"0001419701","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001419701","owner_cik":null,"owner_name":"Longitude Capital Partners, LLC; Longitude Venture Partners L.P.; Tammenoms Bakker Juliet; Longitude Capital Associates, L.P.","owner_display_name":"Longitude Capital Partners, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11927.0,"shares_display":"11,927","price_per_share":30.040201970319444,"price_display":"30.04","price_state":"stated","total_value":358289.4889,"total_display":"358,289.49","total_whole":"358,289","shares_owned_after":1884693.0,"shares_owned_after_display":"1,884,693","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-10-07","filed_date":"2014-10-09","scope":"insider","n_lines":2},{"id":7002565,"accession":"0001144204-14-027615","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001144204-14-027615","line_url":"/filing/0001144204-14-027615","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":null,"owner_name":"Tammenoms Bakker Juliet; Longitude Capital Partners, LLC; Longitude Venture Partners L.P.; Longitude Capital Associates, L.P.","owner_display_name":"Tammenoms Bakker Juliet","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":86443.0,"shares_display":"86,443","price_per_share":4.0718,"price_display":"4.07","price_state":"stated","total_value":351978.6074,"total_display":"351,978.61","total_whole":"351,979","shares_owned_after":12510581.0,"shares_owned_after_display":"12,510,581","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-02","filed_date":"2014-05-05","scope":"insider","n_lines":2},{"id":7002562,"accession":"0001144204-14-027615","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-14-027615","line_url":"/filing/0001144204-14-027615","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":null,"owner_name":"Tammenoms Bakker Juliet; Longitude Capital Partners, LLC; Longitude Venture Partners L.P.; Longitude Capital Associates, L.P.","owner_display_name":"Tammenoms Bakker Juliet","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":163557.0,"shares_display":"163,557","price_per_share":4.1245,"price_display":"4.12","price_state":"stated","total_value":674590.8465,"total_display":"674,590.85","total_whole":"674,591","shares_owned_after":12595325.0,"shares_owned_after_display":"12,595,325","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-01","filed_date":"2014-05-05","scope":"insider","n_lines":2},{"id":7029462,"accession":"0001144204-14-020626","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-14-020626","line_url":"/filing/0001144204-14-020626","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":null,"owner_name":"Longitude Venture Partners L.P.; Longitude Capital Associates, L.P.; Tammenoms Bakker Juliet; Longitude Capital Partners, LLC","owner_display_name":"Longitude Venture Partners L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":250000.0,"shares_display":"250,000","price_per_share":4.2823,"price_display":"4.28","price_state":"stated","total_value":1070575.0,"total_display":"1,070,575.00","total_whole":"1,070,575","shares_owned_after":12755668.0,"shares_owned_after_display":"12,755,668","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-04-01","filed_date":"2014-04-03","scope":"insider","n_lines":2},{"id":7017277,"accession":"0001144204-14-014246","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001144204-14-014246","line_url":"/filing/0001144204-14-014246","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":null,"owner_name":"Longitude Capital Partners, LLC; Tammenoms Bakker Juliet; Longitude Capital Associates, L.P.; Longitude Venture Partners L.P.","owner_display_name":"Longitude Capital Partners, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10430.0,"shares_display":"10,430","price_per_share":4.0,"price_display":"4.00","price_state":"stated","total_value":41720.0,"total_display":"41,720.00","total_whole":"41,720","shares_owned_after":13000756.0,"shares_owned_after_display":"13,000,756","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-07","filed_date":"2014-03-07","scope":"insider","n_lines":2},{"id":7017275,"accession":"0001144204-14-014246","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001144204-14-014246","line_url":"/filing/0001144204-14-014246","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":null,"owner_name":"Longitude Capital Partners, LLC; Tammenoms Bakker Juliet; Longitude Capital Associates, L.P.; Longitude Venture Partners L.P.","owner_display_name":"Longitude Capital Partners, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":168103.0,"shares_display":"168,103","price_per_share":4.0007,"price_display":"4.00","price_state":"stated","total_value":672529.6721,"total_display":"672,529.67","total_whole":"672,530","shares_owned_after":13010981.0,"shares_owned_after_display":"13,010,981","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-06","filed_date":"2014-03-07","scope":"insider","n_lines":2},{"id":7017272,"accession":"0001144204-14-014246","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-14-014246","line_url":"/filing/0001144204-14-014246","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":null,"owner_name":"Longitude Capital Partners, LLC; Tammenoms Bakker Juliet; Longitude Capital Associates, L.P.; Longitude Venture Partners L.P.","owner_display_name":"Longitude Capital Partners, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":71467.0,"shares_display":"71,467","price_per_share":4.0098,"price_display":"4.01","price_state":"stated","total_value":286568.3766,"total_display":"286,568.38","total_whole":"286,568","shares_owned_after":13175781.0,"shares_owned_after_display":"13,175,781","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-05","filed_date":"2014-03-07","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":"2014-03-05|7017270","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001267565","name":"COLLEGIUM PHARMACEUTICAL, INC","url":"/issuer/0001267565","role":"Ten percent owner","n_filings":2,"first_seen":"2015-05-14","last_seen":"2017-12-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001088856","name":"CORCEPT THERAPEUTICS INC","url":"/issuer/0001088856","role":"Director, Ten percent owner","n_filings":10,"first_seen":"2009-02-10","last_seen":"2016-11-25"},{"type":"issuer","type_label":"ISSUER","cik":"0001434868","name":"Esperion Therapeutics, Inc.","url":"/issuer/0001434868","role":"Ten percent owner","n_filings":4,"first_seen":"2013-07-01","last_seen":"2014-11-19"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001419701","retrieved_at":"2026-08-22T23:28:09+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}